Recent Finacing
Recent Raise
Reapplix develops the LeucoPatch system—an on‑demand autologous patch produced with a single‑use device and 3CP centrifuge (no reagents) for treating poorly healing wounds; cleared in EU and US.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
